• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner.胰岛α细胞中的 GLP-1 受体以葡萄糖依赖的双向方式调节胰高血糖素分泌。
Diabetes. 2019 Jan;68(1):34-44. doi: 10.2337/db18-0317. Epub 2018 Nov 2.
2
Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.胰高血糖素受体拮抗剂通过作用于 GLP-1 受体促进糖尿病小鼠胰岛β细胞再生。
Diabetes. 2023 May 1;72(5):599-610. doi: 10.2337/db22-0784.
3
Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism.糖尿病大鼠的胰腺 alpha 细胞表达活性 GLP-1 受体:通过胰岛内旁分泌机制发挥作用的 GLP-1/GLP-1R 复合物的内体共定位。
Sci Rep. 2018 Feb 27;8(1):3725. doi: 10.1038/s41598-018-21751-w.
4
Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.人类胰岛中存在一群胰高血糖素样肽-1 分泌的α细胞,在 2 型糖尿病中这群细胞的数量会增加。
Mol Metab. 2020 Sep;39:101014. doi: 10.1016/j.molmet.2020.101014. Epub 2020 May 12.
5
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.在生理浓度的葡萄糖条件下,胰高血糖素通过β细胞 GCGR 增强胰岛素分泌。
Cells. 2021 Sep 21;10(9):2495. doi: 10.3390/cells10092495.
6
Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.胰高血糖素样肽-1受体存在于胰腺腺泡细胞中,并通过环磷酸腺苷调节淀粉酶分泌。
Am J Physiol Gastrointest Liver Physiol. 2016 Jan 1;310(1):G26-33. doi: 10.1152/ajpgi.00293.2015. Epub 2015 Nov 5.
7
Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.达格列净通过诱导 2 型糖尿病小鼠胰腺内分泌细胞表型转化促进β细胞再生。
Metabolism. 2020 Oct;111:154324. doi: 10.1016/j.metabol.2020.154324. Epub 2020 Jul 23.
8
Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.胰高血糖素样肽1受体基因敲除小鼠中葡萄糖依赖性促胰岛素多肽分泌增强及促胰岛素作用增强
Diabetes. 1998 Jul;47(7):1046-52. doi: 10.2337/diabetes.47.7.1046.
9
Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.多种亲电试剂对胰高血糖素样肽-1受体的正变构调节作用
J Biol Chem. 2016 May 13;291(20):10700-15. doi: 10.1074/jbc.M115.696039. Epub 2016 Mar 14.
10
β Cell GLP-1R Signaling Alters α Cell Proglucagon Processing after Vertical Sleeve Gastrectomy in Mice.β 细胞 GLP-1R 信号在小鼠垂直袖状胃切除术后改变 α 细胞前胰高血糖素加工。
Cell Rep. 2018 Apr 24;23(4):967-973. doi: 10.1016/j.celrep.2018.03.120.

引用本文的文献

1
Exploring the multifaceted roles of GLP-1 receptor agonists; a comprehensive review.探索胰高血糖素样肽-1受体激动剂的多方面作用;全面综述
Front Clin Diabetes Healthc. 2025 Jul 10;6:1590530. doi: 10.3389/fcdhc.2025.1590530. eCollection 2025.
2
Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting.胰高血糖素和葡萄糖可用性影响胰腺神经内分泌肿瘤(pNET)细胞的代谢异质性和恶性程度:治疗靶点的新途径
Molecules. 2025 Jun 25;30(13):2736. doi: 10.3390/molecules30132736.
3
Therapeutic Potential of GLP-1 Receptor Agonists in Heart Failure with Preserved Ejection Fraction (HFpEF) in Obese Patients.胰高血糖素样肽-1受体激动剂在肥胖患者射血分数保留的心力衰竭(HFpEF)中的治疗潜力
Curr Heart Fail Rep. 2025 May 14;22(1):17. doi: 10.1007/s11897-025-00704-1.
4
A Comprehensive Review on the Pharmacokinetics and Drug-Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist.已批准的胰高血糖素样肽-1(GLP-1)受体激动剂和双GLP-1/葡萄糖依赖性促胰岛素多肽(GIP)受体激动剂的药代动力学及药物相互作用综述
Drug Des Devel Ther. 2025 Apr 30;19:3509-3537. doi: 10.2147/DDDT.S506957. eCollection 2025.
5
Ketotic Hypoglycaemia Following Sleeve Gastrectomy.袖状胃切除术后的酮症性低血糖症
Clin Endocrinol (Oxf). 2025 Jul;103(1):45-49. doi: 10.1111/cen.15232. Epub 2025 Mar 25.
6
Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers.使用纳米载体将1型糖尿病治疗药物主动靶向胰腺β细胞。
Diabetologia. 2025 Apr;68(4):692-703. doi: 10.1007/s00125-024-06356-5. Epub 2025 Jan 23.
7
Identification of key genes and regulatory networks involved in the Comorbidity of atrial fibrillation and chronic obstructive pulmonary disease.心房颤动与慢性阻塞性肺疾病共病相关关键基因及调控网络的鉴定
Heliyon. 2023 Nov 17;9(11):e22430. doi: 10.1016/j.heliyon.2023.e22430. eCollection 2023 Nov.
8
Bridging the Gap Between Diabetes and Cardiovascular Disease: A Comparative Review of Different Glucagon-Like Peptide-1 (GLP-1) Agonists: Efficacy, Safety, and Patient Outcomes.弥合糖尿病与心血管疾病之间的差距:不同胰高血糖素样肽-1(GLP-1)激动剂的比较综述:疗效、安全性及患者预后
Cureus. 2024 Nov 24;16(11):e74345. doi: 10.7759/cureus.74345. eCollection 2024 Nov.
9
Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells.2型糖尿病早期的高胰高血糖素血症和胰高血糖素分泌过多是由胰腺小鼠α细胞的多方面失调引起的。
Pflugers Arch. 2025 Feb;477(2):207-221. doi: 10.1007/s00424-024-03045-5. Epub 2024 Nov 27.
10
Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonists.转化肝脂肪变性疾病管理:GLP-1 受体激动剂的新兴作用。
Hepatol Commun. 2024 Oct 10;8(11). doi: 10.1097/HC9.0000000000000561. eCollection 2024 Nov 1.

本文引用的文献

1
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes.胰高血糖素样肽-1及胰高血糖素样肽-1受体激动剂在2型糖尿病治疗中的应用
Ann Pediatr Endocrinol Metab. 2017 Mar;22(1):15-26. doi: 10.6065/apem.2017.22.1.15. Epub 2017 Mar 31.
2
The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice.胰腺前胰高血糖素在小鼠葡萄糖稳态中的作用
Cell Metab. 2017 Apr 4;25(4):927-934.e3. doi: 10.1016/j.cmet.2017.02.008. Epub 2017 Mar 16.
3
Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis.胰高血糖素与氨基酸在相互反馈循环中相互关联:肝脏-α细胞轴。
Diabetes. 2017 Feb;66(2):235-240. doi: 10.2337/db16-0994.
4
Intra-islet glucagon-like peptide 1.胰岛内胰高血糖素样肽1
J Diabetes Complications. 2016 Nov-Dec;30(8):1651-1658. doi: 10.1016/j.jdiacomp.2016.05.016. Epub 2016 May 20.
5
Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male.雄激素受体的核外作用增强雄性个体的葡萄糖刺激的胰岛素分泌。
Cell Metab. 2016 May 10;23(5):837-51. doi: 10.1016/j.cmet.2016.03.015. Epub 2016 Apr 28.
6
The complexity of signalling mediated by the glucagon-like peptide-1 receptor.胰高血糖素样肽-1受体介导的信号传导复杂性。
Biochem Soc Trans. 2016 Apr 15;44(2):582-8. doi: 10.1042/BST20150244.
7
Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.肠促胰岛素疗法:强调胰高血糖素样肽-1受体激动剂和二肽基肽酶-4抑制剂作用模式的共同特征与差异
Diabetes Obes Metab. 2016 Mar;18(3):203-16. doi: 10.1111/dom.12591. Epub 2016 Jan 5.
8
PAX4 Gene Transfer Induces α-to-β Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment.PAX4基因转移诱导α细胞向β细胞的表型转化并为糖尿病治疗带来治疗益处。
Mol Ther. 2016 Feb;24(2):251-260. doi: 10.1038/mt.2015.181. Epub 2015 Oct 5.
9
Glucagon Couples Hepatic Amino Acid Catabolism to mTOR-Dependent Regulation of α-Cell Mass.胰高血糖素将肝氨基酸分解代谢与 mTOR 依赖性α细胞质量调控偶联。
Cell Rep. 2015 Jul 21;12(3):495-510. doi: 10.1016/j.celrep.2015.06.034. Epub 2015 Jul 9.
10
Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.缺乏胰高血糖素和胰岛素的作用揭示了 GLP-1 受体在内源性葡萄糖产生中的作用。
Diabetes. 2015 Mar;64(3):819-27. doi: 10.2337/db14-1052. Epub 2014 Oct 6.

胰岛α细胞中的 GLP-1 受体以葡萄糖依赖的双向方式调节胰高血糖素分泌。

GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner.

机构信息

Section of Endocrinology, Department of Medicine, Tulane University Health Science Center, New Orleans, LA.

Department of Surgery, Medical University of South Carolina, Charleston, SC.

出版信息

Diabetes. 2019 Jan;68(1):34-44. doi: 10.2337/db18-0317. Epub 2018 Nov 2.

DOI:10.2337/db18-0317
PMID:30389749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6302540/
Abstract

Glucagon-like peptide 1 (GLP-1) is known to suppress glucagon secretion, but the mechanism by which GLP-1 exerts this effect is unclear. In this study, we demonstrated GLP-1 receptor (GLP-1R) expression in α-cells using both antibody-dependent and antibody-independent strategies. A novel α-cell-specific GLP-1R knockout (αGLP-1R) mouse model was created and used to investigate its effects on glucagon secretion and glucose metabolism. Male and female αGLP-1R mice both showed higher nonfasting glucagon levels than their wild-type littermates, whereas insulin and GLP-1 levels remained similar. Female αGLP-1R mice exhibited mild glucose intolerance after an intraperitoneal glucose administration and showed increased glucagon secretion in response to a glucose injection compared with the wild-type animals. Furthermore, using isolated islets, we confirmed that αGLP-1R deletion did not interfere with β-cell function but affected glucagon secretion in a glucose-dependent bidirectional manner: the αGLP-1R islets failed to inhibit glucagon secretion at high glucose and failed to stimulate glucagon secretion at very low glucose condition. More interestingly, the same phenomenon was recapitulated in vivo under hypoglycemic and postprandial (fed) conditions. Taken together, this study demonstrates that GLP-1 (via GLP-1R in α-cells) plays a bidirectional role, either stimulatory or inhibitory, in glucagon secretion depending on glucose levels.

摘要

胰高血糖素样肽 1(GLP-1)已知可抑制胰高血糖素的分泌,但 GLP-1 发挥这种作用的机制尚不清楚。在这项研究中,我们使用抗体依赖和非依赖策略证明了α细胞中 GLP-1 受体(GLP-1R)的表达。创建了一种新型的α细胞特异性 GLP-1R 敲除(αGLP-1R)小鼠模型,并用于研究其对胰高血糖素分泌和葡萄糖代谢的影响。雄性和雌性αGLP-1R 小鼠的非空腹胰高血糖素水平均高于其野生型同窝仔鼠,而胰岛素和 GLP-1 水平保持相似。雌性αGLP-1R 小鼠在腹腔内葡萄糖给药后表现出轻度葡萄糖不耐受,并且与野生型动物相比,对葡萄糖注射的胰高血糖素分泌增加。此外,使用分离的胰岛,我们证实αGLP-1R 缺失不干扰β细胞功能,但以葡萄糖依赖性双向方式影响胰高血糖素分泌:αGLP-1R 胰岛在高葡萄糖条件下不能抑制胰高血糖素分泌,在非常低的葡萄糖条件下不能刺激胰高血糖素分泌。更有趣的是,在低血糖和餐后(进食)条件下,同样的现象在体内得到了重现。总之,这项研究表明,GLP-1(通过α细胞中的 GLP-1R)在胰高血糖素分泌中发挥双向作用,即根据葡萄糖水平具有刺激或抑制作用。